Ulcerative colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Females, aged between 20 and 45 years; 2. Patients who meet the criteria of active ulcerative colitis (total Mayo score >= 3); 3. Patients preparing for pregnancy; 4. Patients who willing to participate in the study, sign an informed consent and can be followed up.
Exclusion criteria
Exclusion criteria: 1. Infertility caused by diseases of reproductive system or male infertility; 2. Patients with severe complications such as local stenosis, intestinal obstruction, intestinal perforation, colon cancer, rectal cancer, bacillary dysentery, amoebic dysentery, chronic schistosomiasis and radiation enteritis; 3. Patients who are allergic to the known ingredients and any excipients of the drug in this study; 4. Patients with severe diseases such as liver, kidney, hematopoietic system and mental retardation; 5. Patients who have participated in clinical trials of other drugs in recent 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Mayo score; | — |
Secondary
| Measure | Time frame |
|---|---|
| relapse rate in pregnancy;Faecal calprotectin;Mucosal healing rate;Inflammatory Bowel Disease Quality of Life Questionnaire;pregnancy outcome; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine